Status:
COMPLETED
Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)
Lead Sponsor:
Istanbul Nisantasi University
Conditions:
Covid-19
Eligibility:
All Genders
18-99 years
Brief Summary
Investigators will recruit patients diagnosed with COVID-19 pneumonia between March 11th, 2020 and April 15th, 2020 in emergency, internal medicine and cardiology outpatient clinics, retrospectively a...
Detailed Description
Covid-19 infections demonstrated a pandemic spread after January 2020 and their associations with patient characteristics and comorbidities are intensely studied. Investigators also want to find out p...
Eligibility Criteria
Inclusion
- Covid-19 pneumonia at least with typical infiltration on CT +/- positive PCR.
Exclusion
- no typical infiltration and negative PCR results.
- not newly diagnosed.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 8 2020
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04379310
Start Date
May 1 2020
End Date
May 8 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vital Hospital
Bahçelievler, Istanbul, Turkey (Türkiye), 34230